Clinical Trial Update: Study on the Clinical Efficacy of Teclistamab

View source ↗

Summary

This clinical trial update notes that Teclistamab is currently recruiting to study its clinical efficacy in multiple myeloma and other hematologic diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Diseases
• Multiple Myeloma

Drugs mentioned

• TECVAYLI (TECLISTAMAB-CQYV)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Multiple Myeloma, Hematologic Diseases | Status: RECRUITING